ALK+ Blog/News
- ALK Experts
- ALK International
- ALK Positive News
- Clinical Trials
- Government
- Living with ALK+
- Nutrition
- Patient & Care Partner Stories
- Powered By Patients
- Recipes
- Research
-
ALK Positive Grants Support Dr. Alice Shaw’s Pioneering ALK-Positive Lung Cancer Research
ALK Positive is proud to support Dr. Alice Shaw’s pre-clinical research advancing the understanding of ALK-positive lung cancer. Her work focuses on uncovering biological mechanisms that drive treatment resistance, with the goal of informing future therapeutic strategies and improving long-term outcomes for patients. Through this partnership, ALK Positive is investing in science that accelerates progress…
-
ALK Positive and Pfizer Announce New Grant Opportunity to Improve Education and Support for People Living With Advanced ALK+ Lung Cancer
We’re proud to partner with Pfizer on a new grant opportunity designed to strengthen education for people diagnosed with advanced ALK-positive lung cancer. This RFP supports independent projects that help patients and care partners prepare for treatment, recognize side effects early, and access clear, inclusive resources that honor their preferences. Funding is available for organizations…
-
ALK Positive and the American Association for Cancer Research (AACR) partner to fund a two-year AACR-ALK Positive Lung Cancer Research Fellowship
ALK Positive Partners with AACR to Advance ALK-Positive Lung Cancer Research ALK Positive has partnered with the American Association for Cancer Research (AACR) to fund a two-year AACR–ALK Positive Lung Cancer Research Fellowship supporting early-career investigators in ALK-positive lung cancer research. The 2025 awardee, Alice Tzeng, MD, PhD of Dana-Farber Cancer Institute, is studying epigenetic…
-
ALK Positive Inc. Appoints Dr. Ken Culver as Executive Director & Medical Director to Lead Research and Patient Advocacy Initiatives
ALK Positive has appointed Dr. Ken Culver as Executive Director and Medical Director to guide the organization’s strategy and research investments. A physician-scientist with expertise in oncology and drug development, Dr. Culver has advanced patient-driven science and global collaborations since joining ALK Positive in 2022. His leadership marks an exciting new chapter in accelerating research…
-
Carrying Forward a Legacy: An Interview with Chad David Jasso of the Dave Jasso Foundation
The Dave Jasso Foundation exists with a dual mission: to actively fundraise for ALK Positive, supporting their critical research in the fight against ALK-positive lung cancer, and to honor the enduring legacy of Dave Jasso.
-
A Study of Gilteritinib in Adults with Advanced ALK-Positive Non-small Cell Lung Cancer (NSCLC) Sponsored by Astellas
This trial is for patients progressing on >1 prior ALK inhibitor with measurable, locally advanced or metastatic, ALK-positive non-small cell lung cancer who have experienced alectinib as their only prior ALK inhibitor regimen, or have received lorlatinib as one of their prior ALK inhibitor regimens.
-
Participate in Survey to Help our Medical Committee
The ALK Positive Inc. Medical Committee is seeking patient and caregiver input to enhance DDI Manager — an online resource that helps identify potential drug–drug interactions between cancer treatments and other medications. Your feedback can make a real difference in improving this tool for the entire ALK+ community. Participation takes just 10–15 minutes.
-
Takeda Oncology Co-Pay Assistance Progam
As of October 1, 2025, ALUNBRIG® (brigatinib) is now covered at Cigna Healthcare, giving most commercial patients faster access and lower out-of-pocket costs. With this update, about 99% of commercial lives are covered for ALUNBRIG. Learn more about co-pay assistance at takedaoncologycopay.com .
-
Introducing ALK Positive Canada
An interview with Katie Hulan, VP of Advocacy, ALK Positive Canada
-
Sheet Pan Red Pepper and Roast Tomato Soup
If you’re wondering what to do with those end of the season tomatoes on your window sills, or if you simply appreciate what the produce markets offer, this is for you ! Easy as it is delicious, just chop, roast, and blend. Serve with your favorite crusty bread ! By Chef and fellow ALKie Juli…
-
The Colin Barton Spirit of Courage Award
At the 2025 ALK Summit in San Diego, ALK Positive proudly introduced the Colin Barton Spirit of Courage Award—a tribute to the vision, leadership, and tireless dedication of one of our founding members. From helping launch the organization and leading the Medical Committee, to personally funding research and inspiring millions in donations, Colin’s courage has…
-
Clinical Trial Spotlight: Recruiting for Early-Stage ALK-Positive Lung Cancer
For years, people with ALK-positive lung cancer have faced a frustrating reality: while targeted therapies have transformed outcomes for stage IV disease, treatment for earlier stages has lagged behind. For stage I–III cancers—where surgery, chemo, or radiation may be a cure—there’s been little clarity on whether targeted drugs could reduce recurrence and improve survival.